Cargando…
Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)
Pharmacogenomics (PGx) is a key subset of precision medicine that relates genomic variation to individual response to pharmacotherapy. We assessed longitudinal trends in US FDA approval of new drugs labeled with PGx information. Drug labels containing PGx information were obtained from Drugs@FDA and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000585/ https://www.ncbi.nlm.nih.gov/pubmed/33806453 http://dx.doi.org/10.3390/jpm11030179 |